M Zaffaroni
Overview
Explore the profile of M Zaffaroni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
132
Citations
706
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Gironi M, Solaro C, Meazza C, Vaghi M, Montagna L, Rovaris M, et al.
Mult Scler Int
. 2013 Nov;
2013:836486.
PMID: 24260717
Evidence suggests that neurohormones such as GH and IGF-I are involved in the neuroreparative processes in multiple sclerosis (MS). GH and IGF-I blood levels in naïve MS patients with different...
12.
Pellai A, Festa F, Cilento F, Grossi L, Grassino E, Zaffaroni M, et al.
Minerva Pediatr
. 2013 Sep;
65(5):531-40.
PMID: 24056379
Aim: The aim of this paper was to know and analyze information, attitudes and behaviors related with transformations occurring in men when they become fathers. Methods: A self-administered questionnaire has...
13.
Ghezzi A, Rocca M, Baroncini D, Annovazzi P, Zaffaroni M, Minonzio G, et al.
J Neurol
. 2012 Nov;
260(1):327-9.
PMID: 23161460
No abstract available.
14.
Ghezzi A, Carone R, Del Popolo G, Amato M, Bertolotto A, Comola M, et al.
Neurol Sci
. 2011 Sep;
32(6):1223-31.
PMID: 21948057
Urinary disorders are uncommon in the initial phases of multiple sclerosis, but increase in frequency as the disease progresses, with a negative impact on quality of life. The goal of...
15.
Ghezzi A, Pozzilli C, Grimaldi L, Brescia Morra V, Bortolon F, Capra R, et al.
Neurology
. 2010 Sep;
75(10):912-7.
PMID: 20820002
Objective: To describe the effect of natalizumab in the treatment of subjects with active multiple sclerosis (MS) treated before the age of 18 years. Methods: Nineteen pediatric subjects with MS...
16.
Chiarini M, Sottini A, Ghidini C, Zanotti C, Serana F, Rottoli M, et al.
Mult Scler
. 2009 Dec;
16(2):218-27.
PMID: 20007428
The immunomodulating activity of glatiramer acetate on T-cells of multiple sclerosis patients has only been partially clarified. The objective of this work was to investigate whether glatiramer acetate modifies thymic...
17.
Tue P, Mannheimer R, Bertino E, Fiore M, Zaffaroni M, Navone C, et al.
Minerva Pediatr
. 2009 Nov;
61(6):593-6.
PMID: 19935501
No abstract available.
18.
Benedetti B, Rocca M, Rovaris M, Caputo D, Zaffaroni M, Capra R, et al.
J Neurol Neurosurg Psychiatry
. 2009 Jun;
81(1):26-30.
PMID: 19546104
Background: Diffusion tensor (DT) MRI enables quantification of the severity of brain and cervical cord pathology in multiple sclerosis (MS). Objective: To investigate DT MRI patterns of cervical cord damage...
19.
Benedetti B, Rovaris M, Rocca M, Caputo D, Zaffaroni M, Capra R, et al.
Mult Scler
. 2009 May;
15(7):789-94.
PMID: 19465450
Objective: The term benign multiple sclerosis (BMS) is referred to patients who have a mild or absent disability several years after disease clinical onset. Axonal damage can be measured in...
20.
Gironi M, Martinelli-Boneschi F, Sacerdote P, Solaro C, Zaffaroni M, Cavarretta R, et al.
Mult Scler
. 2008 Aug;
14(8):1076-83.
PMID: 18728058
A sixth month phase II multicenter-pilot trial with a low dose of the opiate antagonist Naltrexone (LDN) has been carried out in 40 patients with primary progressive multiple sclerosis (PPMS)....